We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
The Tumor Suppressor PP2A as a Therapeutic Target for Eradication of TKI-resistant Ph+ Leukemic Stem Cells
Host: Ross Levine, MD
Tea will be served at 4:15 pm.
This program is for the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
Room ZRC 105
New York, NY 10065
Human Oncology and Pathogenesis Program
Danilo Perrotti, MD, PhD
Molecular Virology, Immunnology, and Genetics
Ohio State University